Company Filing History:
Years Active: 2020
Title: Manjunath Lamani: Innovator in Cannabinoid Research
Introduction
Manjunath Lamani is a notable inventor based in Medford, MA, who has made significant contributions to the field of cannabinoid research. His work focuses on developing innovative compounds that target specific therapeutic conditions related to cannabinoid receptor function.
Latest Patents
Lamani holds a patent for "ABHD6 and dual ABHD6/MGL inhibitors and their uses." This patent encompasses compounds and pharmaceutical compositions designed to selectively inhibit serine hydrolase a/b-hydrolase domain 6 (ABHD6) and dually inhibit ABHD6 and monoacylglycerol lipase (MGL). The disclosed compounds are particularly useful for treating various therapeutic conditions, including pain, inflammation, neuropathy, neurodegenerative diseases, anxiety disorders, motor function disorders, metabolic disorders, glaucoma, chemotherapy-induced nausea and vomiting, and cancer.
Career Highlights
Manjunath Lamani is associated with Makscientific, LLC, where he continues to advance his research and development efforts. His innovative approach has positioned him as a key player in the field of cannabinoid therapeutics.
Collaborations
Lamani collaborates with esteemed colleagues, including Alexandros Makriyannis and Michael Sotirios Malamas, who contribute to his research endeavors and enhance the impact of his work.
Conclusion
Manjunath Lamani's contributions to cannabinoid research through his innovative patents and collaborations highlight his role as a significant inventor in the field. His work promises to advance therapeutic options for various medical conditions.